Allergan Gets Positive Opinion For Its Truberzi For Irritable Bowel Syndrome With Diarrhoea Treatment In Adults
July 25, 2016 at 13:13 PM EDT
Allergan plc (NYSE: AGN) revealed that the Committee for Medicinal Products for Human Use (CHMP) has adopted a favorable Opinion for ...